Loading...
Updates and challenges on treatment with BRAF/MEK-inhibitors in melanoma
INTRODUCTION: Breakthroughs in targeted therapy have significantly improved outcomes for many patients with advanced melanoma, including those with BRAFV600 mutant disease. Targeted therapy for BRAFV600-mutant metastatic melanoma includes combinations of BRAF inhibitors and MEK inhibitors, which imp...
Na minha lista:
| Udgivet i: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296476/ https://ncbi.nlm.nih.gov/pubmed/30574432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2018.1512402 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|